MétaCan
Menu
Back to cohort
Record W4247614496 · doi:10.2174/1874120701004010025

Achieving a Dream: Meeting Policy Goals Related to Improving Drug Access

2010· article· en· W4247614496 on OpenAlexaff
David Zakus

Bibliographic record

VenueThe Open AIDS Journal · 2010
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicPharmaceutical Economics and Policy
Canadian institutionsPublic Health OntarioCanadian Society for International HealthUniversity of TorontoHealth Canada
Fundersnot available
KeywordsHuman immunodeficiency virus (HIV)MedicineFace (sociological concept)Access to medicinesPublic relationsEconomic growthDeveloping countryDevelopment economicsInternet privacyPolitical scienceSocial scienceSociologyFamily medicineEconomicsComputer science

Abstract

fetched live from OpenAlex

International experts recognize that significant inequities exist in the accessibility of life-saving medicines among poor and vulnerable populations, especially in developing countries.This article highlights that drug access even for relatively cheap medicines is out of reach for the vast numbers of global poor.This badly affects people living with HIV/AIDS who face serious obstacles in accessing ARVs.The same concerns are attributed to neglected diseases.Despite international meetings, promises from the pharmaceutical industry and a lot of media attention little has changed in the past 20 years.The accessibility gap to life-saving drugs could be reduced by the UNITAID initiative to pool patents for the many different ARVs, but the reality is that UNITAID is still a promise.To surmount this global problem of inequity requires a rethinking of traditional models of drug access and health objectives that should not be compromised by commercial interests.Life saving and life-enhancing properties are the foundation of the moral and commercial significance of drugs.Pharmaceuticals are not ordinary "goods".With about 25 million persons living with HIV/AIDS still without access to needed drugs, the HIV/AIDS pandemic illuminated that access to life saving medicines is a basic human right, which is now becoming recognised worldwide.This is accepted internationally, for example, under the International Covenant on Economic, Social and Cultural Rights, in which Article 12 states that national governments have the responsibility to ensure and protect the right of their populations to the "highest attainable standard of physical and mental health" emphasizing health as an "inalienable and universal" human right.The UN Commission on Human Rights (2001) calls on States "to promote the right to health through access to affordable treatments and…(the) provision of essential drugs".In spite of international appeal experts recognize that significant gaps exist in the agreement with respect to patent protection and access to as well as availability of life-saving medicines in developing countries.According to Gro Harlem Brundtland, former Director-General of WHO (WHO, 2000): "At the beginning of the 21 st Century, one-third of the world's population still lacks access to the essential drugs it needs for good health.In the poorest parts of Africa and Asia, over 50% of the population do not have access to the most vital drugs".

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.017
metaresearch head score (Gemma)0.035
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.017
Threshold uncertainty score0.091

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0170.035
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.002
Science and technology studies0.0030.007
Scholarly communication0.0110.023
Open science0.0020.008
Research integrity0.0170.011
Insufficient payload (model declined to judge)0.0140.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.054
GPT teacher head0.358
Teacher spread0.304 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueThe Open AIDS JournalSame topicPharmaceutical Economics and PolicyFrench-language works237,207